Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deoxycholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104193792B reveals a one-step microwave-assisted conversion of chenodeoxycholic acid. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ursodeoxycholic acid.
Advanced refining method for Hyodeoxycholic Acid ensures high purity and safety. Ideal for pharmaceutical intermediates manufacturing with reduced costs and scalable supply chain solutions.
Novel enzymatic method for UDCA and TUDCA from pig bile. High purity, scalable process. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN112341512A details a novel route converting seal cholic acid to chenodeoxycholic acid, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Patent CN120081889B reveals a one-pot hydrogenation method for high-purity chenodeoxycholic acid, offering significant cost reduction in API manufacturing and scalable production.
Patent CN107573396B details a novel two-step chromatography method achieving >97.5% purity CDCA. Ideal for reliable pharmaceutical intermediates supply chains.
Novel plant-derived synthesis route for Ursodeoxycholic Acid ensures high purity and supply continuity. Ideal for pharmaceutical intermediates manufacturing.
Patent CN111410675A reveals a low-cost oxidation method for 3 7-diketocholanic acid. Enhances purity and yield for pharmaceutical intermediates manufacturing supply chains.
Patent CN102766185A details a novel method for recovering ursodesoxycholic acid and chenodeoxycholic acid from waste mother liquor, offering significant cost reduction and supply chain reliability.
Discover a novel synthetic route for ursodesoxycholic acid from chenodeoxycholic acid featuring high optical purity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN106868534B enables mild electro-catalytic synthesis. Delivers high-purity bile acids with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel stigmasterol based UDCA preparation method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing processes.
Novel 9-step synthesis for deoxycholic acid intermediates. Reduces steps, increases yield to 31.5%. Ideal for pharmaceutical supply chains and cost reduction.
Patent CN105418716A details a novel duck bile extraction method for Chenodeoxycholic acid. This process ensures high purity and significant cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN1912192B reveals a green electrochemical route for 7-keto lithocholic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110669091A reveals a novel DIPEA salt crystallization method for high-purity ursodeoxycholic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced purification process for ursodeoxycholic acid ensures 99.8% purity. Optimized solvent usage reduces energy consumption for reliable pharmaceutical intermediate supply chains.
Novel chenodeoxycholic acid route offers high purity lithocholic acid. Safe reagents and scalable process reduce manufacturing costs for pharmaceutical supply chains.
Advanced P450 enzyme mutant technology enables efficient ursodeoxycholic acid production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN114539342B reveals an industrial method for TUDCA using alcohol solvents to reduce impurities, offering cost-effective pharma intermediate manufacturing.